In SSc‐ILD patients, Cav‐1 expression is diminished in leukocytes, particularly in PMNs and monocytes/macrophages, resulting in altered signaling pathways that drive the advancement of pulmonary fibrosis [95]. The gene discussed is CAV1; the disease is systemic sclerosis.